Mechanisms of resolution of inflammation: a focus on cardiovascular disease
- PMID: 21508346
- DOI: 10.1161/ATVBAHA.110.213850
Mechanisms of resolution of inflammation: a focus on cardiovascular disease
Abstract
The inflammatory response is an integral part of the innate immune mechanism that is triggered in response to a real or perceived threat to tissue homeostasis, with a primary aim of neutralizing infectious agents and initiating repair to damaged tissue. By design, inflammation is a finite process that resolves as soon as the threat of infection abates and sufficient repair to the tissue is complete. Resolution of inflammation involves apoptosis and subsequent clearance of activated inflammatory cells--a tightly regulated event. Chronic inflammation is a characteristic feature in virtually all inflammatory diseases, including atherosclerosis, and it is becoming increasingly clear that derangement of the processes usually involved in resolution of inflammation is an underlying feature of chronic inflammatory conditions. This review will draw on evidence from a range of diseases in which dysregulated inflammation is important, with particular emphasis on cardiovascular disease.
Similar articles
-
Targeting inflammation in cardiovascular diseases. still a neglected field?Cardiovasc Ther. 2012 Aug;30(4):e189-97. doi: 10.1111/j.1755-5922.2011.00274.x. Epub 2011 Apr 1. Cardiovasc Ther. 2012. PMID: 21884009 Review.
-
Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions.Atherosclerosis. 2018 Sep;276:98-108. doi: 10.1016/j.atherosclerosis.2018.07.014. Epub 2018 Jul 25. Atherosclerosis. 2018. PMID: 30055326 Review.
-
Lipid oxidation and cardiovascular disease: introduction to a review series.Circ Res. 2010 Nov 12;107(10):1167-9. doi: 10.1161/CIRCRESAHA.110.224618. Circ Res. 2010. PMID: 21071714 No abstract available.
-
Inflammation in atherosclerosis: transition from theory to practice.Circ J. 2010 Feb;74(2):213-20. doi: 10.1253/circj.cj-09-0706. Epub 2010 Jan 9. Circ J. 2010. PMID: 20065609 Review.
-
Novel pharmacological strategies for driving inflammatory cell apoptosis and enhancing the resolution of inflammation.Trends Pharmacol Sci. 2008 May;29(5):250-7. doi: 10.1016/j.tips.2008.03.002. Epub 2008 Apr 11. Trends Pharmacol Sci. 2008. PMID: 18407359 Review.
Cited by
-
Selenium Deficiency Facilitates Inflammation Through the Regulation of TLR4 and TLR4-Related Signaling Pathways in the Mice Uterus.Inflammation. 2015;38(3):1347-56. doi: 10.1007/s10753-014-0106-9. Inflammation. 2015. PMID: 25577343
-
Regulation and consequences of monocytosis.Immunol Rev. 2014 Nov;262(1):167-78. doi: 10.1111/imr.12219. Immunol Rev. 2014. PMID: 25319334 Free PMC article. Review.
-
Management of inflammation in cardiovascular diseases.Pharmacol Res. 2021 Nov;173:105912. doi: 10.1016/j.phrs.2021.105912. Epub 2021 Sep 23. Pharmacol Res. 2021. PMID: 34562603 Free PMC article. Review.
-
Impact of NSAIDs corticosteroids DMARDs biologics and their comparisons with natural products in C-reactive proteins (CRP) linked cardiovascular disorders.Inflammopharmacology. 2025 May;33(5):2537-2563. doi: 10.1007/s10787-025-01767-1. Epub 2025 May 4. Inflammopharmacology. 2025. PMID: 40319427 Review.
-
Low-molecular-weight fucoidan protects endothelial function and ameliorates basal hypertension in diabetic Goto-Kakizaki rats.Lab Invest. 2014 Apr;94(4):382-93. doi: 10.1038/labinvest.2014.12. Epub 2014 Mar 10. Lab Invest. 2014. PMID: 24614196
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources